Premium
Omnichannel pharmacy chain Pharmeasy plans to raise ₹2,500 crore ($304 million) to retire the senior debt it had raised from Goldman Sachs, said two people with knowledge of the development. While ₹1,000 crore will come from Manipal Group’s Ranjan Pai’s family office, existing investors in Pharmeasy are expected to pump ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
